Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Future directions in the prevention of prostate cancer.

Literature DB >> 24281061

Future directions in the prevention of prostate cancer.

Ian M Thompson¹, April B Cabang¹, Michael J Wargovich¹.

Abstract

The high global incidence of prostate cancer has led to a focus on chemoprevention strategies to reduce the public health impact of the disease. Early studies indicating that selenium and vitamin E might protect against prostate cancer encouraged large-scale studies that produced mixed clinical results. Next-generation prostate cancer prevention trials validated the impact of 5α-reductase inhibitors in hormone-responsive prostate cancer, and these results were confirmed in follow-up studies. Other interventions on the horizon, involving both dietary and pharmacological agents, hold some promise but require further investigation to validate their efficacy. In this Review, we discuss the clinical and preclinical evidence for dietary and pharmacological prevention of prostate cancer and give an overview of future opportunities for chemoprevention.

Entities: CellLine Chemical Disease Gene Mutation Species

Mesh：

Substances：

Year: 2013 PMID： 24281061 PMCID： PMC5034727 DOI： 10.1038/nrclinonc.2013.211

Source DB: PubMed Journal: Nat Rev Clin Oncol ISSN： 1759-4774 Impact factor: 66.675

137 in total

1. Enhancement of curcumin oral absorption and pharmacokinetics of curcuminoids and curcumin metabolites in mice.

Authors: Liu Zhongfa; Ming Chiu; Jiang Wang; Wei Chen; Winston Yen; Patty Fan-Havard; Lisa D Yee; Kenneth K Chan
Journal: Cancer Chemother Pharmacol Date: 2011-10-04 Impact factor: 3.333

Review 2. Resveratrol: Biological and pharmaceutical properties as anticancer molecule.

Authors: Tze-chen Hsieh; Joseph M Wu
Journal: Biofactors Date: 2010 Sep-Oct Impact factor: 6.113

3. Statin and NSAID use and prostate cancer risk.

Authors: Patricia F Coogan; Judith Parsells Kelly; Brian L Strom; Lynn Rosenberg
Journal: Pharmacoepidemiol Drug Saf Date: 2010-07 Impact factor: 2.890

Review 4. Resveratrol bioavailability and toxicity in humans.

Authors: Charles-Henry Cottart; Valérie Nivet-Antoine; Christelle Laguillier-Morizot; Jean-Louis Beaudeux
Journal: Mol Nutr Food Res Date: 2010-01 Impact factor: 5.914

5. Dietary resveratrol prevents development of high-grade prostatic intraepithelial neoplastic lesions: involvement of SIRT1/S6K axis.

Authors: Guiming Li; Paul Rivas; Roble Bedolla; Dinesh Thapa; Robert L Reddick; Rita Ghosh; Addanki P Kumar
Journal: Cancer Prev Res (Phila) Date: 2012-12-17

6. Epigallocatechin gallate promotes p53 accumulation and activity via the inhibition of MDM2-mediated p53 ubiquitination in human lung cancer cells.

Authors: Longyu Jin; Cui Li; Yan Xu; Li Wang; Jianxin Liu; Dianjun Wang; Cao Hong; Zhibing Jiang; Yuchao Ma; Qian Chen; Fenglei Yu
Journal: Oncol Rep Date: 2013-03-12 Impact factor: 3.906

7. Preparation and characterization of curcumin-piperine dual drug loaded nanoparticles.

Authors: C Moorthi; Kiran Krishnan; R Manavalan; K Kathiresan
Journal: Asian Pac J Trop Biomed Date: 2012-11

8. Resveratrol worsens survival in SCID mice with prostate cancer xenografts in a cell-line specific manner, through paradoxical effects on oncogenic pathways.

Authors: Joseph C Klink; Alok K Tewari; Elizabeth M Masko; Jodi Antonelli; Phillip G Febbo; Pinchas Cohen; Mark W Dewhirst; Salvatore V Pizzo; Stephen J Freedland
Journal: Prostate Date: 2012-11-28 Impact factor: 4.104

9. Use of non-steroidal anti-inflammatory drugs and prostate cancer risk: a population-based nested case-control study.

Authors: Salaheddin M Mahmud; Eduardo L Franco; Donna Turner; Robert W Platt; Patricia Beck; David Skarsgard; Jon Tonita; Colin Sharpe; Armen G Aprikian
Journal: PLoS One Date: 2011-01-28 Impact factor: 3.240

10. Curcumin attenuates β-catenin signaling in prostate cancer cells through activation of protein kinase D1.

Authors: Vasudha Sundram; Subhash C Chauhan; Mara Ebeling; Meena Jaggi
Journal: PLoS One Date: 2012-04-16 Impact factor: 3.240

16 in total

1. Effect of Metformin, Rapamycin, and Their Combination on Growth and Progression of Prostate Tumors in HiMyc Mice.

Authors: Achinto Saha; Jorge Blando; Lisa Tremmel; John DiGiovanni
Journal: Cancer Prev Res (Phila) Date: 2015-04-23

2. Lessons learned about prostatic transformation from the age-related methylation of 5α-reductase type 2 gene.

Authors: John T Isaacs
Journal: Am J Pathol Date: 2015-02-17 Impact factor: 4.307

3. Prostate Cancer Xenograft Inhibitory Activity and Pharmacokinetics of Decursinol, a Metabolite of Angelica gigas Pyranocoumarins, in Mouse Models.

Authors: Wei Wu; Su-Ni Tang; Yong Zhang; Manohar Puppala; Timothy K Cooper; Chengguo Xing; Cheng Jiang; Junxuan Lü
Journal: Am J Chin Med Date: 2017-11-09 Impact factor: 4.667

Future directions in the prevention of prostate cancer.

1. Enhancement of curcumin oral absorption and pharmacokinetics of curcuminoids and curcumin metabolites in mice.

Review 2. Resveratrol: Biological and pharmaceutical properties as anticancer molecule.

3. Statin and NSAID use and prostate cancer risk.

Review 4. Resveratrol bioavailability and toxicity in humans.

5. Dietary resveratrol prevents development of high-grade prostatic intraepithelial neoplastic lesions: involvement of SIRT1/S6K axis.

6. Epigallocatechin gallate promotes p53 accumulation and activity via the inhibition of MDM2-mediated p53 ubiquitination in human lung cancer cells.

7. Preparation and characterization of curcumin-piperine dual drug loaded nanoparticles.

8. Resveratrol worsens survival in SCID mice with prostate cancer xenografts in a cell-line specific manner, through paradoxical effects on oncogenic pathways.

9. Use of non-steroidal anti-inflammatory drugs and prostate cancer risk: a population-based nested case-control study.

10. Curcumin attenuates β-catenin signaling in prostate cancer cells through activation of protein kinase D1.

1. Effect of Metformin, Rapamycin, and Their Combination on Growth and Progression of Prostate Tumors in HiMyc Mice.

2. Lessons learned about prostatic transformation from the age-related methylation of 5α-reductase type 2 gene.

3. Prostate Cancer Xenograft Inhibitory Activity and Pharmacokinetics of Decursinol, a Metabolite of Angelica gigas Pyranocoumarins, in Mouse Models.

Review 4. Glycogen synthase kinase-3: a potential preventive target for prostate cancer management.

5. Is There a Future for Chemoprevention of Prostate Cancer?

6. MicroRNA-143 acts as a tumor suppressor by targeting hexokinase 2 in human prostate cancer.

7. PSMA-specific theranostic nanoplex for combination of TRAIL gene and 5-FC prodrug therapy of prostate cancer.

8. A Perspective on Prostate Carcinogenesis and Chemoprevention.

Review 9. Prostate cancer chemoprevention by natural agents: Clinical evidence and potential implications.

10. Broccoli-Derived Sulforaphane and Chemoprevention of Prostate Cancer: From Bench to Bedside.